Business Context and Reporting Period
Company: Champions Oncology, Inc. (CSBR)
Filing Type: Form 8-K (Current Report)
Report Date: September 10, 2026
Reporting Period: First quarter ended July 31, 2026
Context: The Company issued a press release regarding its unaudited financial results for the quarter. The 8-K serves as a notification of this release and includes the press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text is a cover sheet and does not contain specific numerical data. The following metrics are referenced in the attached press release (Exhibit 99.1) but are not detailed in this document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release containing unaudited results but does not include specific management commentary, forward-looking guidance, or risk factors within the text of the 8-K itself.
Unusual Items: No unusual items are described in the filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated September 10, 2026) for actual revenue, net income, and cash position figures.
- Verify the specific unaudited nature of the reported results as stated in Item 2.02.
- Check for any forward-looking statements or updated guidance contained within the attached press release.
- Confirm the trading symbol (CSBR) and exchange (Nasdaq) for accurate market data correlation.